1Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease[J]. Stroke,2011,42:3304-3310.
2Nishimoto A, Takeuchi S. Abnormal cerebrovascular network rel- ated to the internal cartoid arteries [ J ]. J Neurosurg, 1968,29: 255 -260.
3Suzuki J, Kodaraa N. Moyamoya disease a review [ J ]. Stroke, 1983,14 : 104-109.
4Okada Y, Kawamata T, Kawashima A, et al. The efficacy ofsuperficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache [ J ]. J Neurosurg,2012,116:672-679.
5Takahashi JC, Miyamoto S. Moyamoya disease: recent progress and outlook [ J]. Neurol Med Chit (Tokyo) ,2010,50:824-832.
6Patel NN, Mangano FT, Klimo P Jr. Indirect revascularization techniques for treating moyamoya disease [ J ]. Neurosurg Clin N Am,2010,21:553-563.
7Baaj AA, Agazzi S, Sayed ZA, et al. Surgical management of moyamoya disease : a review [ J ]. Neurosurg Focus,2009,26 : E7.
8Houkin K, Kamiyama H, Abe H, et al. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? [ J ]. Stroke, 1996, 27 : 1342-1346.
9Fujimura M, Kaneta T, Shimizu H, et al. Symptomatic hype- rperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease [ J ]. Childs Nerv Syst,2007,23 : 1195-1198.
10Fujimura M, Mugikura S, Kaneta T, et al. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease[J]. Surg Neurol,2009,71:442-447.
